We are thrilled to announce that Rajendra Apte, MD, PhD has recently been awarded a $300,000 Research to Prevent Blindness (RPB)/American Macular Degeneration Foundation (AMDF) Catalyst Award for Innovative Research Approaches for AMD.
This prestigious award serves as a testament to Dr. Apte’s commitment to advancing knowledge in the field of ophthalmology, particularly in the critical area of age-related macular degeneration (AMD). With the incidence of AMD on the rise and its profound impact on vision, the need for innovative research approaches is more pressing than ever.
The RPB/AMDF Catalyst Award is specifically designed to support novel and groundbreaking research that aims to unravel the complexities of AMD. Dr. Apte’s work will contribute significantly to the collective effort to find effective treatments for this increasingly common and debilitating condition.
The Research to Prevent Blindness (RPB) organization, established in 1960, has been a pioneering force in eye research, channeling over $413 million into groundbreaking studies. RPB has played a pivotal role in virtually every major breakthrough in vision research over the past six decades.
For those interested in exploring RPB’s extensive grants program, as well as gaining insights into the impactful research generated by their awards, please visit www.rpbusa.org.
The American Macular Degeneration Foundation (macular.org) is a non-profit organization committed to the prevention, treatment, and cure of macular degeneration, and empowering those with AMD to live to the fullest.